NSEAcquisition18 Jun 2026 · 18 Jun 2026, 12:20 pm

Acquisition

Aster DM Healthcare Limited · ASTERDM

✦ AI SummaryM&A

Aster DM Healthcare Limited has acquired 4,50,89,995 equity shares in its wholly owned subsidiary, Aster DM Super-Specialty Hospital (Sarjapur) Private Limited, through a rights issue.

Analysis Scores

Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Aster DM Healthcare Limited has informed the Exchange about Acquisition

Attachments (1)

📄

ASTERDM2_18062026121918_STXSarjapurRightssigned.pdf

pdf

Download →
View document text
June 18, 2026 To To The Secretary, The Manager, Listing Department, Listing Department, BSE Limited, The National Stock Exchange of India Ltd, 1st Floor, Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex, Dalal Street, Mumbai 400001. Bandra (East), Mumbai 400051. Scrip Code: 540975 Scrip Symbol: ASTERDM Dear Sir/ Madam, Sub: Intimation of acquisition of 4,50,89,995 equity shares in Aster DM Super-Specialty Hospital (Sarjapur) Private Limited (“Sarjapur Entity”), a subsidiary of Aster DM Healthcare Limited (“Company”) Ref: Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) Pursuant to Regulation 30 of the SEBI Listing Regulations, this is to inform you that the Company today, i.e. June 18, 2026, has acquired 4,50,89,995 equity shares of Rs. 10/- each through rights issue in the Sarjapur Entity. The details as required under Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are given in “Annexure I”. The above-mentioned information will also be available on the website of the Company at https://www.asterdmhealthcare.in. We request you to kindly take the above information on record. Thanking you, For Aster DM Healthcare Limited Hemish Purushottam Company Secretary and Compliance Officer M. No. A24331 Annexure I Details as required under Regulation 30 of the SEBI Listing Regulations read along with SEBI Master Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 Sr. Particulars Details 1 Name of the target entity, details in brief Name: Aster DM Super-Specialty Hospital (Sarjapur) such as size, turnover etc. Private Limited (“Sarjapur Entity”) Date of incorporation: July 21, 2025 Authorized Share Capital: Rs. 153,55,00,000/- (Rupee One Hundred and Fifty-Three Crore and Fifty- Five Lakhs Only) comprising 10,00,00,000 equity shares of Rs.10/- each, 38,40,000 Series A compulsorily convertible preference shares of Rs. 50/- each and 68,70,000 Series B compulsorily convertible preference shares of Rs. 50/- each. Paid-up Share Capital: Rs. 50,10,00,000/- (Rupee Fifty Crore and Ten Lakhs Only) comprising 5,01,00,000 equity shares of Rs. 10/- each Size/Turnover: Not applicable, since the entity is yet to commence its business. 2 Whether the acquisition would fall within Sarjapur Entity, being a wholly owned subsidiary of related party transaction(s) and whether the Company, is a related party of the Company. The the promoter/ promoter group/ group transaction falls within the ambit of related party companies have any interest in the entity transactions. However, the transaction is between a being acquired? If yes, nature of interest holding company and wholly owned subsidiary, and and details thereof and whether the same as such exempted from the provisions in respect of is done at “arm’s length” related party transactions as per Regulation 23(5) of SEBI Listing Regulations. Apart from the aforesaid, the promoter / promoter group/ group companies do not have any interest in Sarjapur Entity. The transaction is done at an arm’s length basis. Sr. Particulars Details 3 Industry to which the entity being Healthcare services acquired belongs 4 Objects and impact of acquisition The investment by the Company is being made for (including but not limited to, disclosure of general corporate purposes of the Sarjapur entity. reasons for acquisition of target entity, if its business is outside the main line of business of the listed entity) 5 Brief details of any governmental or Not Applicable regulatory approvals required for the acquisition; 6 Indicative time period for completion of Sarjapur Entity has allotted 4,50,89,995 equity the acquisition; shares of Rs. 10/- each on June 18, 2026. 7 Consideration - whether cash Cash consideration consideration or share swap or any other form and details of the same; 8 Cost of acquisition and/or the price at Rs. 45,08,99,950/- comprising of 4,50,89,995 equity which the shares are acquired; shares of Rs. 10/- each 9 Percentage of shareholding / control 100% shareholding of the Sarjapur Entity is held by acquired and / or number of shares the Company. acquired; 4,50,89,995 equity shares of Rs. 10/- each have been acquired. 10 Brief background about the entity Sarjapur Entity has been incorporated on July 21, acquired in terms of products/line of 2025, in Bengaluru, Karnataka, India, inter alia, to business acquired, date of incorporation, carry on the business of setting up and operating history of last 3 years turnover, country in healthcare services. which the acquired entity has presence and any other significant information (in Turnover: Not applicable, since the entity is yet to brief); commence its business.